Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Psychosis and Antipsychotic Drugs: Overview01:28

Psychosis and Antipsychotic Drugs: Overview

The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic symptoms in all...
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Positive Symptoms Schizophrenia: Hallucinations and Delusions01:26

Positive Symptoms Schizophrenia: Hallucinations and Delusions

Schizophrenia is a complex psychiatric disorder characterized by a range of symptoms that significantly impact cognition, behavior, and emotional regulation. Among these, the positive symptoms stand out as they involve the addition or exaggeration of normal mental functions, deviating markedly from typical behavior and perception. Hallucinations and delusions are prominent positive symptoms, each profoundly affecting the individual's experience of reality.
Hallucinations
Hallucinations in...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...
Positive Symptoms of Schizophrenia: Hallucinations and Delusions01:30

Positive Symptoms of Schizophrenia: Hallucinations and Delusions

Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes loosely...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Being parent is associated with suicidal history in people with serious mental illness enrolled in psychiatric rehabilitation.

Journal of psychiatric research·2021
Same author

Cognitive remediation and professional insertion of people with schizophrenia: RemedRehab, a randomized controlled trial.

European psychiatry : the journal of the Association of European Psychiatrists·2021
Same author

Stigma resistance is associated with advanced stages of personal recovery in serious mental illness patients enrolled in psychiatric rehabilitation.

Psychological medicine·2020
Same author

Multidisciplinary consensus recommendations from a European network for the diagnosis and practical management of patients with incontinentia pigmenti.

Journal of the European Academy of Dermatology and Venereology : JEADV·2020
Same author

Self-stigma in serious mental illness and autism spectrum disorder: Results from the REHABase national psychiatric rehabilitation cohort.

European psychiatry : the journal of the Association of European Psychiatrists·2020
Same author

[In process].

Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg·2018

Related Experiment Video

Updated: Jun 7, 2026

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
11:05

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients

Published on: February 6, 2021

[Iatrogenic psychiatric-like symptoms recognition].

C Demily1, V-A Chouinard, G Chouinard

  • 1Centre de neuroscience cognitive (CNRS UMR 5229 et Université Lyon-1), Bron, France. caroline.demily@isc.cnrs.fr

L'Encephale
|November 2, 2010
PubMed
Summary

Distinguishing drug-induced movement disorders (DIMD) from true relapse is crucial for effective antipsychotic treatment. Early identification and management of DIMD and supersensitivity psychosis can improve patient outcomes and prevent misdiagnosis.

Related Experiment Videos

Last Updated: Jun 7, 2026

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients
11:05

SECONDs Administration Guidelines: A Fast Tool to Assess Consciousness in Brain-injured Patients

Published on: February 6, 2021

Area of Science:

  • Psychiatry
  • Pharmacology
  • Movement Disorders

Context:

  • Antipsychotic medications are essential for managing psychosis.
  • Drug-induced movement disorders (DIMD) and supersensitivity psychosis are potential adverse effects.
  • Distinguishing these conditions from true psychotic relapse is clinically challenging.

Purpose:

  • To review atypical antipsychotic studies focusing on DIMD and related psychiatric symptoms.
  • To differentiate between true relapse and drug-induced psychiatric symptoms.
  • To explore the relationship between DIMD, supersensitivity psychosis, and treatment outcomes.

Summary:

  • Persistent DIMD can predict supersensitivity psychosis or tardive dyskinesia (TD).
  • DIMD-associated psychiatric symptoms require careful classification to avoid masking antipsychotic efficacy.
  • A decline in TD prevalence is noted with atypical antipsychotics, but risk remains, necessitating ongoing surveillance.

Impact:

  • Accurate diagnosis of DIMD and supersensitivity psychosis improves antipsychotic treatment efficacy.
  • This distinction helps prevent misattribution of symptoms and inappropriate treatment adjustments.
  • Understanding these drug-induced conditions aids in managing treatment-resistant schizophrenia and optimizing patient care.